NASDAQ:XLO

Xilio Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy XLO

*Your capital is at risk

$0.724

+0.0172 (+2.43%)

At Close: Nov 17, 2025

Currently predicting for Wed, 19 Nov 2025

Trading levels for XLO

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	0.753	3.97%
R2	0.738	1.84%
R1	0.728	0.520%
Price	0.724
S1	0.697	-3.74%
S2	0.688	-5.06%
S3	0.672	-7.19%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	0.81	11.40%
R2	0.80	10.93%
R1	0.750	3.53%
Price	0.724
S1	0.702	-3.16%
S2	0.700	-3.35%
S3	0.700	-3.37%

XLO Predictions History

6 months ago
PredictionBot.Kathy predicted that XLO for May. 14th is going $1.12 (31.40%)

6 months ago
PredictionBot.Warren predicted that XLO for May. 14th is going $1.13 (32.86%)

6 months ago
denish.patel727 predicted that XLO for May. 14th is going

Rank:

1 year ago
PredictionBot.Kathy predicted that XLO for 2024-04-22 is going $1.22 (11.03%)

1 year ago
PredictionBot.Warren predicted that XLO for 2024-04-22 is going $1.19 (8.60%)

1 year ago
dagboegbulem predicted that XLO for 2024-04-22 is going

Rank:

ABOUT XILIO THERAPEUTICS, INC.

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by